BriaCell Therapeutics Corp. - Common Shares, no par value per share (the "Shares") (BCTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025

Type / Class
Equity / Common Shares, no par value per share (the "Shares")
Symbol
BCTX on Nasdaq
Shares outstanding
7,179,159
Price per share
$10.92
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
12,427
Total reported value
$136,489
% of total 13F portfolios
0%
Share change
+12,427
Value change
+$136,489
Number of holders
12
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BriaCell Therapeutics Corp. - Common Shares, no par value per share (the "Shares") (BCTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CITADEL ADVISORS LLC 10% $5,119,574 717,198 Kenneth Griffin 15 Jan 2026
Iroquois Capital Management, LLC 5% $1,088,384 98,944 Richard Abbe 30 Sep 2025
CVI Investments, Inc. 4.9% $1,088,384 98,944 CVI Investments, Inc. 30 Sep 2025

As of 30 Sep 2025, 12 institutional investors reported holding 12,427 shares of BriaCell Therapeutics Corp. - Common Shares, no par value per share (the "Shares") (BCTX). This represents 0.17% of the company’s total 7,179,159 outstanding shares.

Institutional Holders of BriaCell Therapeutics Corp. - Common Shares, no par value per share (the "Shares") (BCTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 4,763 $33,865 +$32,302 $7.11 5
2025 Q3 12,427 $136,489 +$136,489 $11.00 12